![]() |
Volumn 17, Issue 3, 2008, Pages 133-142
|
Switching from methylphenidate immediate release to MPH-SODAS™ in attention-deficit/hyperactivity disorder
|
Author keywords
Attention deficit hyperactivity disorder; Hyperactivity; Inattention; Methylphenidate; Methylphenidate spheroidal oral drug absorption system
|
Indexed keywords
METHYLPHENIDATE;
ADOLESCENT;
ADULT;
ANXIETY;
APPETITE;
ARTICLE;
ATTENTION DEFICIT DISORDER;
BRAIN HEMORRHAGE;
CARDIOVASCULAR DISEASE;
CEREBROVASCULAR ACCIDENT;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED RELEASE FORMULATION;
DROWSINESS;
DRUG ABSORPTION;
DRUG DELIVERY SYSTEM;
DRUG SAFETY;
EUPHORIA;
FEMALE;
HABIT;
HEADACHE;
HUMAN;
INSOMNIA;
IRRITABILITY;
MALE;
MENTAL PATIENT;
OPEN STUDY;
PATIENT SATISFACTION;
QUESTIONNAIRE;
RATING SCALE;
SCHOOL CHILD;
SIDE EFFECT;
SLEEP DISORDER;
SOCIAL INTERACTION;
TREATMENT DURATION;
TREATMENT OUTCOME;
UNSPECIFIED SIDE EFFECT;
ADMINISTRATION, ORAL;
ADULT;
ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOR DISORDERS;
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;
CENTRAL NERVOUS SYSTEM STIMULANTS;
CHILD;
COMORBIDITY;
CONDUCT DISORDER;
DELAYED-ACTION PREPARATIONS;
DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
MALE;
METHYLPHENIDATE;
QUESTIONNAIRES;
|
EID: 43149094008
PISSN: 10188827
EISSN: 1435165X
Source Type: Journal
DOI: 10.1007/s00787-007-0647-7 Document Type: Article |
Times cited : (6)
|
References (56)
|